Leserbrief zum Beitrag „Stellungnahme der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. (DGGG) zur Lancet-Studie ‚Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence‘ [29. August 2019; doi:10.1016/S0140-6736(19)31709-X]“

2020 ◽  
Vol 80 (02) ◽  
pp. 153-153 ◽  
Author(s):  
Martin Kolben
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Meta Analysis ◽  
Menopausal Hormone Therapy ◽  
Epidemiological Evidence ◽  
Individual Participant

scholarly journals Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life

2018 ◽  
Vol 34 (3) ◽  
pp. 267-278
Author(s):  
Marie Søfteland Sandvei ◽  
Lars J. Vatten ◽  
Elisabeth Krefting Bjelland ◽  
Anne Eskild ◽  
Solveig Hofvind ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Body Mass ◽  
Effect Modification ◽  
Menopausal Hormone Therapy ◽  
Risk Effect

Abstract 655: Menopausal hormone therapy and breast cancer risk: The CECILE Study

2012 ◽  
Author(s):  
Emilie Cordina-Duverger ◽  
Thérèse Truong ◽  
Antoinette Anger ◽  
Claire Mulot ◽  
Patrick Arveux ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Hormone Therapy ◽  
Menopausal Hormone Therapy
Sign in / Sign up

Export Citation Format

Share Document